Collapse to view only § 10202. General provisions
§ 10201. Evaluation
(a) Guidelines and comprehensive evaluations
To increase the efficiency and effectiveness of programs funded under this subchapter, the National Institute of Justice shall—
(1) develop guidelines, in cooperation with the Bureau of Justice Assistance, to assist State and local units of government to conduct program evaluations; and
(2) conduct a reasonable number of comprehensive evaluations of programs funded under section 10156 (formula grants) and section 10171 (discretionary grants) of this title.
(b) Criteria for selecting programs for review
In selecting programs for review, the Director of the National Institute of Justice should consider—
(1) whether the program establishes or demonstrates a new and innovative approach to drug or crime control;
(2) the cost of the program to be evaluated and the number of similar programs funded under section 10156 (formula grants) of this title;
(3) whether the program has a high potential to be replicated in other jurisdictions; and
(4) whether there is substantial public awareness and community involvement in the program. Routine auditing, monitoring, and internal assessment of a State and local drug control program’s progress shall be the sole responsibility of the Bureau of Justice Assistance.
(c) Annual report
(Pub. L. 90–351, title I, § 520, as added Pub. L. 100–690, title VI, § 6091(a), Nov. 18, 1988, 102 Stat. 4337; amended Pub. L. 101–647, title XVIII, § 1801(b), Nov. 29, 1990, 104 Stat. 4848; Pub. L. 109–162, title XI, § 1111(c)(2)(B), Jan. 5, 2006, 119 Stat. 3101.)
§ 10202. General provisions
(a) The Bureau shall prepare both a “Program Brief” and “Implementation Guide” document for proven programs and projects to be funded under this subchapter.
(b) The functions, powers, and duties specified in this subchapter to be carried out by the Bureau shall not be transferred elsewhere in the Department of Justice unless specifically hereafter authorized by the Congress by law.
(c)
(1) Notwithstanding any other provision of law, a grantee that uses funds made available under this subchapter to purchase an armor vest or body armor shall—
(A) comply with any requirements established for the use of grants made under subchapter XXIV;
(B) have a written policy requiring uniformed patrol officers to wear an armor vest or body armor; and
(C) use the funds to purchase armor vests or body armor that meet any performance standards established by the Director of the Bureau of Justice Assistance.
(2) In this subsection, the terms “armor vest”and “body armor” have the meanings given such terms in section 10533 of this title.
(d)Trauma Kits.—
(1)Definition.—In this subsection, the term “trauma kit” means a first aid response kit, which includes a bleeding control kit that can be used for controlling a life-threatening hemorrhage.
(2)Requirement for trauma kits.—
(A)In general.—Notwithstanding any other provision of law, a grantee may only purchase a trauma kit using funds made available under this subchapter if the trauma kit meets the performance standards established by the Director of the Bureau of Justice Assistance under paragraph (3)(A).
(B)Authority to separately acquire.—Nothing in subparagraph (A) shall prohibit a grantee from separately acquiring the components of a trauma kit and assembling complete trauma kits that meet the performance standards.
(3)Performance standards and optional agency best practices.—Not later than 180 days after December 18, 2025, the Director of the Bureau of Justice Assistance, in consultation with organizations representing trauma surgeons, emergency medical response professionals, emergency physicians, other medical professionals, relevant law enforcement agencies of States and units of local government, professional law enforcement organizations, local law enforcement labor or representative organizations, and law enforcement trade associations, shall—
(A) develop and publish performance standards for trauma kits that are eligible for purchase using funds made available under this subchapter that, at a minimum, require the components described in paragraph (4) to be included in a trauma kit; and
(B) develop and publish optional best practices for law enforcement agencies regarding—
(i) training law enforcement officers in the use of trauma kits;
(ii) the deployment and maintenance of trauma kits in law enforcement vehicles; and
(iii) the deployment, location, and maintenance of trauma kits in law enforcement agency or other government facilities.
(4)Components.—The components of a trauma kit described in this paragraph are—
(A) a tourniquet recommended by the Committee on Tactical Combat Casualty Care;
(B) a bleeding control bandage;
(C) a pair of nonlatex protective gloves and a pen-type marker;
(D) a pair of blunt-ended scissors;
(E) instructional documents developed—
(i) under the “Stop the Bleed” national awareness campaign of the Department of Homeland Security, or any successor thereto;
(ii) by the American College of Surgeons Committee on Trauma;
(iii) by the American Red Cross; or
(iv) by any partner of the Department of Defense;
(F) a bag or other container adequately designed to hold the contents of the kit; and
(G) any additional trauma kit supplies that—
(i) are approved by a State, local, or Tribal law enforcement agency or first responders;
(ii) can adequately treat a traumatic injury; and
(iii) can be stored in a readily available kit.
(Pub. L. 90–351, title I, § 521, as added Pub. L. 100–690, title VI, § 6091(a), Nov. 18, 1988, 102 Stat. 4337; amended Pub. L. 114–155, § 6, May 16, 2016, 130 Stat. 390; Pub. L. 119–60, div. H, title LXXXII, § 8203, Dec. 18, 2025, 139 Stat. 1844.)
§ 10203. Reports
(a) Each State which receives a grant under section 10156 of this title shall submit to the Director, for each year in which any part of such grant is expended by a State or unit of local government, a report which contains—
(1) a summary of the activities carried out with such grant and an assessment of the impact of such activities on meeting the purposes of part A;
(2) a summary of the activities carried out in such year with any grant received under part B by such State;
(3) the evaluation result of programs and projects;
(4) an explanation of how the Federal funds provided under this subchapter were coordinated with State agencies receiving Federal funds for drug abuse education, prevention, treatment, and research activities; and
(5) such other information as the Director may require by rule.
Such report shall be submitted in such form and by such time as the Director may require by rule.
(b) Not later than 180 days after the end of each fiscal year for which grants are made under this subchapter, the Director shall submit to the Speaker of the House of Representatives and the President pro tempore of the Senate a report that includes with respect to each State—
(1) the aggregate amount of grants made under part A and part B to such State for such fiscal year;
(2) the amount of such grants awarded for each of the purposes specified in part A;
(3) a summary of the information provided in compliance with paragraphs (1) and (2) of subsection (a);
(4) an explanation of how Federal funds provided under this subchapter have been coordinated with Federal funds provided to States for drug abuse education, prevention, treatment, and research activities; and
(5) evaluation results of programs and projects and State strategy implementation.
(Pub. L. 90–351, title I, § 522, as added Pub. L. 100–690, title VI, § 6091(a), Nov. 18, 1988, 102 Stat. 4337; amended Pub. L. 109–162, title XI, § 1111(c)(2)(C), Jan. 5, 2006, 119 Stat. 3101.)